Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes
NCT01995890 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 327
Last updated 2013-11-27
Summary
The Nevanac product information insert says that it can cause increase in eye pressure in 5-10% of patients. There is very little published literature on the effect of topical Nepafenac eye drops on eye pressure in normal people. The purpose of our study is to report this effect with a working hypothesis that there is no increase in eye pressure following use of Nepafenac eye drops.
Conditions
- Intraocular Pressure
Interventions
- DRUG
-
nepafenac
Sponsors & Collaborators
-
Dr T V Patel Eye Institute
lead OTHER
Principal Investigators
-
Paaraj R Dave, MD · TV Patel Eye Institute
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-04-30
Countries
- India
Study Locations
More Related Trials
-
Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma
NCT03960866 ·Status: COMPLETED ·Phase: PHASE2
-
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
NCT01345448 ·Status: UNKNOWN ·Phase: PHASE2
-
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
NCT04412096 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT02339584 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
NCT04983589 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
NCT01033422 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection
NCT02140450 ·Status: COMPLETED ·Phase: NA
-
Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia
NCT05393089 ·Status: WITHDRAWN ·Phase: PHASE2
-
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00691717 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
NCT00402493 ·Status: COMPLETED ·Phase: NA
-
A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia
NCT02595528 ·Status: COMPLETED ·Phase: PHASE2
-
Anecortave Acetate in Patients With Open-angle Glaucoma
NCT00320203 ·Status: COMPLETED ·Phase: PHASE2
-
Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution
NCT02874846 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
NCT06449352 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Brimonidine
NCT03959176 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
NCT00945958 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
NCT00443924 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
NCT01284309 ·Status: COMPLETED ·Phase: PHASE1
-
Glaucoma Biomarkers
NCT01677507 ·Status: COMPLETED ·Phase: PHASE4
-
Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD
NCT04891588 ·Status: UNKNOWN ·Phase: NA
-
A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
NCT02083289 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
NCT00451152 ·Status: COMPLETED ·Phase: PHASE2
-
How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?
NCT06369077 ·Status: TERMINATED ·Phase: PHASE4
-
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
NCT00315640 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes
NCT02136589 ·Status: COMPLETED ·Phase: PHASE4